Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis

[1]  Xiao-Nan Li,et al.  Targeting metabolism in breast cancer: How far we can go? , 2016, World journal of clinical oncology.

[2]  Zhipeng Wang,et al.  Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer , 2016, Tumor Biology.

[3]  R. Jain,et al.  Emerging strategies for treating brain metastases from breast cancer. , 2015, Cancer cell.

[4]  M. Tan,et al.  Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers , 2015, Oncotarget.

[5]  W. Jung,et al.  Site-specific metabolic phenotypes in metastatic breast cancer , 2014, Journal of Translational Medicine.

[6]  Lin Zhao,et al.  Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells , 2014, Oncotarget.

[7]  F. Montemurro,et al.  Metastatic breast cancer subtypes and central nervous system metastases. , 2014, Breast.

[8]  T. Nishikata,et al.  Simultaneous Expression of Cancer Stem Cell-Like Properties and Cancer-Associated Fibroblast-Like Properties in a Primary Culture of Breast Cancer Cells , 2014, Cancers.

[9]  Jun Zhang,et al.  A Novel KLF4/LDHA Signaling Pathway Regulates Aerobic Glycolysis in and Progression of Pancreatic Cancer , 2014, Clinical Cancer Research.

[10]  G. Yousef,et al.  Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma , 2014, Molecular Cancer.

[11]  A. Evans,et al.  Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma , 2014, Molecular Cancer.

[12]  Suyun Huang,et al.  FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA Expression , 2014, Clinical Cancer Research.

[13]  N. Lin,et al.  CNS Metastases in Breast Cancer: Old Challenge, New Frontiers , 2013, Clinical Cancer Research.

[14]  A. Biswas,et al.  Retrospective analysis of the clinical and demographic variables on the outcomes after second-line treatment in advanced non-small cell lung cancer , 2013, Indian Journal of Medical and Paediatric Oncology.

[15]  B. Zhang,et al.  Gamma‐glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[16]  Quentin Liu,et al.  High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma. , 2013, European journal of cancer.

[17]  M. Gore,et al.  Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma , 2013, British Journal of Cancer.

[18]  Y. Xiong,et al.  Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. , 2013, Cancer cell.

[19]  Jean-Fred Fontaine,et al.  Estrogen-Related Receptor Alpha Modulates Lactate Dehydrogenase Activity in Thyroid Tumors , 2013, PloS one.

[20]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[21]  N. Sato,et al.  Clinical outcomes by relative docetaxel dose and dose intensity as chemotherapy for Japanese patients with castration-resistant prostate cancer: a retrospective multi-institutional collaborative study , 2014, International Journal of Clinical Oncology.

[22]  Heng Zhao,et al.  LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma , 2013, Tumor Biology.

[23]  Junjeong Choi,et al.  Metabolism-Related Proteins Are Differentially Expressed according to the Molecular Subtype of Invasive Breast Cancer Defined by Surrogate Immunohistochemistry , 2012, Pathobiology.

[24]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[25]  I. Nagtegaal,et al.  Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. , 2012, European journal of cancer.

[26]  B. Milleron,et al.  Factors associated with long‐term survival of patients with advanced non‐small cell lung cancer , 2012, Respirology.

[27]  F. Schmitt,et al.  GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. , 2011, Histology and histopathology.

[28]  T. Copetti,et al.  Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review , 2011, Front. Pharmacol..

[29]  R. Blasberg,et al.  Metabolic Imaging: A Link between Lactate Dehydrogenase A, Lactate, and Tumor Phenotype , 2011, Clinical Cancer Research.

[30]  Mary E. Edgerton,et al.  Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer , 2011, PloS one.

[31]  A. Harris,et al.  Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy , 2011, Clinical Cancer Research.

[32]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[33]  Andrew Kramar,et al.  Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Li-Yan Xu,et al.  A Combined Proteomics and Metabolomics Profiling of Gastric Cardia Cancer Reveals Characteristic Dysregulations in Glucose Metabolism* , 2010, Molecular & Cellular Proteomics.

[35]  Karen Gelmon,et al.  Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  M Tan,et al.  Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth , 2009, Oncogene.

[37]  K. Sugihara,et al.  Lactate Dehydrogenase-5 (LDH-5) Expression in Human Gastric Cancer: Association with Hypoxia-Inducible Factor (HIF-1α) Pathway, Angiogenic Factors Production and Poor Prognosis , 2008, Annals of Surgical Oncology.

[38]  E. Mouret‐Fourme,et al.  Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score. , 2007, International journal of radiation oncology, biology, physics.

[39]  A. Jovanovic,et al.  M-LDH serves as a regulatory subunit of the cytosolic substrate-channelling complex in vivo. , 2007, Journal of molecular biology.

[40]  Hong-Yup Ahn,et al.  Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. , 2007, European journal of cancer.

[41]  P. Major,et al.  Hypoxia-induced lactate dehydrogenase expression and tumor angiogenesis. , 2007, Clinical colorectal cancer.

[42]  J. Yates,et al.  Adaptation of energy metabolism in breast cancer brain metastases. , 2007, Cancer research.

[43]  A. Harris,et al.  Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[45]  Gordon B Mills,et al.  mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. , 2006, Cancer research.

[46]  K. Augoff,et al.  [Significance of lactate dehydrogenase measurements in diagnosis of malignancies]. , 2004, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[47]  L. Rutqvist,et al.  Radiation therapy in the management of brain metastases from breast cancer , 2000, Breast Cancer Research and Treatment.

[48]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[50]  T. Ohtsubo,et al.  Acidic environment causes apoptosis by increasing caspase activity , 1999, British Journal of Cancer.

[51]  C. Paraskeva,et al.  An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis , 1999, Oncogene.

[52]  R A Deyo,et al.  Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. , 1986, Journal of chronic diseases.